FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer
recent articles
FDA: Device Delivers Non-invasive Therapy and Supports Care at Home White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with...
Proscia: Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital pathology KNOXVILLE, Tenn. and PHILADELPHIA — February 17, 2026 — NeuroScience Associates (NSA Labs), a specialized contract...
Indica Labs: Learn how to develop your own AI algorithms for segmentation, classification, and more using HALO AI Getting Started With HALO AI Date: 5 March 2026 Time: 8:00 – 9:00 EST | 13:00 – 14:00 GMT | 14:00 – 15:00...
Albuquerque, NM, February 12, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced recognition by KLAS for top customer-rated performance in the European digital pathology market. Best...
From the Proscia blog: Concentriq AP v4.11 delivers key updates across image management, pathology experience, and enterprise controls to help labs run faster and smarter. This release builds on Proscia’s recognition as Global 2026...
Albuquerque, NM, February 10, 2025 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the expansion of its macrodissection portfolio with the launch of Breast Macrodissect AI. The suite...































